0001174264-15-000001.txt : 20150708 0001174264-15-000001.hdr.sgml : 20150708 20150708130422 ACCESSION NUMBER: 0001174264-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150708 DATE AS OF CHANGE: 20150708 EFFECTIVENESS DATE: 20150708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INFACARE PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001174264 IRS NUMBER: 311807488 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-243247 FILM NUMBER: 15978569 BUSINESS ADDRESS: STREET 1: 8 NESHAMINY INTERPLEX, SUITE 221 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: 267-515-5850 MAIL ADDRESS: STREET 1: 8 NESHAMINY INTERPLEX, SUITE 221 CITY: TREVOSE STATE: PA ZIP: 19053 D 1 primary_doc.xml X0707 D LIVE 0001174264 INFACARE PHARMACEUTICAL CORP 8 NESHAMINY INTERPLEX, SUITE 221 TREVOSE PA PENNSYLVANIA 19053 267-515-5850 DELAWARE None None Corporation true Dan Burns 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Executive Officer Director Ron Goldfuss 8 Neshaminy interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Executive Officer Peter Barrett c/o InfaCare Pharmaceutical Corporation 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director William Crouse c/o InfaCare Pharmaceutical Corporation 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Patrick Enright c/o InfaCare Pharmaceutical Corporation 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Robert Vukovich c/o InfaCare Pharmaceutical Corporation 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Harold Werner c/o InfaCare Pharmaceutical Corporation 8 Neshaminy Interplex, Suite 221 Trevose PA PENNSYLVANIA 19053 Director Pharmaceuticals Decline to Disclose 06b false 2015-06-24 false true true Securities issued in the offering include shares of the issuer's Series C Convertible Preferred Stock issued upon the conversion of certain Convertible Promissory Notes in the aggregate principal amount of $2,050,000 with accrued interest of $72,485. false 0 12100000 12100000 0 false 10 0 0 600000 Amount to be paid to related persons represents ordinary salary, excluding fringe costs. false INFACARE PHARMACEUTICAL CORP /s/ Ronald Goldfuss Ronald Goldfuss Chief Financial Officer 2015-07-08